HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).

Abstract
Erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935), provokes marked antihypertensive effects lasting several hours in conscious SHR (0.63 to 40 mg/kg i.p.) and beagles with renal hypertension (1.25 mg/kg p.o.). In SHR, this compound induces much less bradycardia, compared to equiactive hypotensive doses of clonidine, guanethidine and propranolol. Significant postural hypotension during tilting, is induced by guanethidine and mecamylamine but not by R 28935. In anaesthetized beagles with renal hypertension, the lowering of the blood pressure by R 28935, (0.02-0.64 mg/kg i.v.) is associated with a considerable decrease in the total peripheral vascular resistance, whereas the myocardial function is not affected. R 28935 is considered a potent antihypertensive drug, with attractive haemodynamic characteristics.
AuthorsD Wellens, L Snoeckx, R De Reese, R Kruger, A Van de Water, L Woutens, R S Reneman
JournalArchives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) Vol. 215 Issue 1 Pg. 119-32 (May 1975) ISSN: 0003-9780 [Print] Belgium
PMID1156041 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Benzimidazoles
  • Propranolol
  • Clonidine
Topics
  • Animals
  • Antihypertensive Agents (pharmacology, therapeutic use)
  • Benzimidazoles (pharmacology, therapeutic use)
  • Blood Pressure (drug effects)
  • Cardiac Output (drug effects)
  • Clonidine (pharmacology, therapeutic use)
  • Dogs
  • Female
  • Heart Rate (drug effects)
  • Hypertension (drug therapy)
  • Hypertension, Renal (drug therapy)
  • Male
  • Propranolol (pharmacology, therapeutic use)
  • Rats
  • Rats, Inbred Strains
  • Time Factors
  • Vascular Resistance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: